Naomi and I talk about the work ofDr. James Fadamen of The Microdosing Institute, the difference between tripping and microdosing, the legalisation of plant medicines.

To participate in the mushrooms and motherhood survety go here:

The study to which Naomi refers is the Lancet's 2016, Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study